...
首页> 外文期刊>Bulletin of the Aquaculture Association of Canada >The Efficacy of Oral Immunostimulants in Enhancing Resistance against Microsporidiosis in Juvenile Atlantic Cod (Gadus morhua L.)
【24h】

The Efficacy of Oral Immunostimulants in Enhancing Resistance against Microsporidiosis in Juvenile Atlantic Cod (Gadus morhua L.)

机译:口服免疫刺激剂增强大西洋鳕鱼(Gadus morhua L.)对微孢子虫病的抵抗力

获取原文
获取原文并翻译 | 示例
           

摘要

The intracellular parasite Loma morhua (Microsporidia) can induce severe pathology in juvenile Atlantic cod (Gadus morhua L.), characterized by the formation of conspicuous white xenomas in the gills, heart, and spleen. In the absence of suitable chemotherapeutants and given the potential problem of microsporidiosis to a commercial cod aquaculture industry, studies are ongoing to determine the efficacy of various commercial immunostimulant products as prophylactic treatments. In the present study, juvenile, hatchery-reared cod were fed a formulated gadoid diet treated with one of four immunostimulant products, while control groups received untreated feed. Immunostimulant formulations were based on one of three product classes: beta-glucans, bioflavinoid, or nucleotide supplements. To evaluate product efficacy, growth rates were monitored, and random, peripheral blood samples were analyzed for lymphocyte density as an indicator of immune system activity. Finally, the cod were exposed to the infective spores of L. morhua, and the trials were terminated either two (Trial 1) or six weeks (Trial 2) post-challenge. Increased terminal lymphocyte densities were found in all beta-glucan groups for both trials and decreased prev -alence of heavy to severe infections with L. morhua for both beta-glucan and nucleotide supplement groups in Trial 2.
机译:细胞内寄生虫Loma morhua(Microsporidia)可以在幼年大西洋鳕(Gadus morhua L.)中诱发严重的病理,其特征是在the,心脏和脾脏中形成明显的白色异瘤。在缺乏合适的化学治疗剂的情况下,考虑到商业鳕鱼养殖业存在微孢子虫病的潜在问题,正在进行研究以确定各种商业免疫刺激产品作为预防性治疗的功效。在本研究中,给幼稚园,孵化场饲养的鳕鱼喂食了配制的,用四种免疫刺激产品之一处理过的速效饲料,而对照组则接受了未经处理的饲料。免疫刺激剂制剂基于以下三种产品类别之一:β-葡聚糖,生物类黄酮或核苷酸补充剂。为了评估产品功效,监测了生长速率,并分析了随机,外周血样本的淋巴细胞密度,以此作为免疫系统活性的指标。最后,将鳕鱼暴露于莫氏乳杆菌的感染性孢子,并在攻击后两周(试验1)或六周(试验2)终止试验。在两个试验中,所有β-葡聚糖组的终末淋巴细胞密度均增加,而β-葡聚糖和核苷酸补充剂组的莫氏乳杆菌重度至重度感染的发生率降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号